Accolade, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2024 12 months to Feb 29, 2024	FY2023 12 months to Feb 28, 2023	FY2022 12 months to Feb 28, 2022	FY2021 12 months to Feb 28, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Goodwill impairment
Depreciation and amortization expense
Amortization of deferred contract acquisition costs
Change in fair value of contingent consideration
Deferred income taxes
Noncash interest expense (income)
Accretion of discounts/premiums on marketable securities, net
Stock‑based compensation expense
Gain on repurchase of convertible notes
Changes in operating assets and liabilities:
Accounts receivable and unbilled revenue
Accounts payable and accrued expenses
Deferred contract acquisition costs
Deferred revenue and due to customers
Accrued compensation
Other liabilities
Other assets
Net cash used in operating activities
Cash flows from investing activities:
Capitalized software development costs
Purchases of property and equipment
Purchase of marketable securities
Sale of marketable securities
Cash paid for acquisitions, net of cash acquired
Earnout payments to MD Insider
Net cash used in investing activities

Cash flows from financing activities:
Payments for repurchase of convertible notes
Payments for debt extinguishment costs
Proceeds from employee stock purchase plan
Proceeds from stock option exercises
Payment of contingent consideration for acquisition
Payments of equity issuance costs
Payment of debt issuance costs
Payment for purchase of capped calls
Proceeds from borrowings on debt
Proceeds from public offerings, net of underwriters' discounts and commissions and offering costs
Repayments of debt principal
Net cash provided (used) by financing activities

Net decrease in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental cash flow information:
Interest paid
Issuance of common stock in lieu of cash bonus
Fixed assets included in accounts payable
Other receivable related to stock option exercises
Income taxes paid
Common stock issued in connection with acquisitions
Replacement awards issued in connection with acquisitions
Common stock issued in connection with acquisition

Comments